The only candidate that was found to be differentially expressed in our results and in validation data is APBA2; this protein interacts with amyloid precursor proteins which are involved in the development of Alzheimer’s disease. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.